Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

BACKGROUND/AIMS: It remains to be determined whether switching from adefovir (ADV) to tenofovir (TDF) provides better virological outcomes in patients exhibiting suboptimal responses to ADV plus nucleoside analogue (ADV+NA) therapy for NA-resistant chronic hepatitis B (CHB). METHODS: In this prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Won, Park, Jun Yong, Kim, Beom Kyung, Kim, Moon Young, Lee, Jung Il, Kim, Young Suk, Yoon, Ki Tae, Han, Kwang-Hyub, Ahn, Sang Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266340/
https://www.ncbi.nlm.nih.gov/pubmed/27880997
http://dx.doi.org/10.3350/cmh.2016.0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266340/
https://www.ncbi.nlm.nih.gov/pubmed/27880997
http://dx.doi.org/10.3350/cmh.2016.0037

Ejemplares similares